Bayzed Health Group, Inc.

Bayzed Health Group, Inc.

HHKEX:2609
2.68
HKD
-0.01
(-0.56%)
5.04BMarket Cap
Bayzed Health Group, Inc.
HKEX:2609
(Hong Kong Exchange)

Recent

price

2.68

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
TTM
CNY
0.35
0.61
0.81
0.9
0.89
- -
Revenue per Share
-0.03
-0.04
-0.02
-0.01
-0.01
- -
Basic EPS, GAAP
-0.04
0.06
0.06
0.09
0.15
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
0.78
0.75
0.82
0.81
1.15
1.15
Book Value per Share
0.22
0.05
0.13
0.12
0.47
0.47
Tangible Book Value per Share
1,318
1,318
1,318
1,318
1,255
1,318
Basic Weighted Avg Shares
462
803
1,072
1,189
1,120
- -
Sales/Revenue/Turnover
-8.85
-4.83
2.01
2.68
2.14
- -
Operating Margin (%)
50
75
86
87
91
- -
Depreciation Expense
-46
-58
-26
-13
-13
- -
Net Income, GAAP
- -
- -
- -
126.72
193.39
- -
Effective Tax Rate (%)
-9.99
-7.23
-2.46
-1.13
-1.16
- -
Profit Margin (%)
205
-129
-2
-24
472
472
Working Capital
260
234
251
202
198
198
LT Debt
1,104
1,086
1,176
1,170
1,621
1,621
Total Equity
- -
- -
- -
-0.49
-1.13
- -
Return on Invested Capital (%)
- -
- -
- -
-1.72
-1.94
- -
Return on Capital (%)
- -
-5.77
-2.55
-1.25
-1
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
315
340
346
LT Borrowings
65
108
74
LT Finance Leases
137
128
124
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,318
1,318
1,318
Market Capitalization
- -
7,424
4,526

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
758
1,248
1,161
Cash, Cash Equivalents & STI
276
835
607
Accounts Receivable, Net
228
215
223
Inventories
63
58
60
Total Current Liabilities
782
749
689
Payables & Accruals
- -
- -
- -
ST Debt
315
340
346
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
38.5%
Free Cash Flow
- -
- -
51.07%
Net Income, GAAP
- -
- -
-3.72%
Sales/Revenue/Turnover
- -
- -
-5.8%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1,072
2024
- -
- -
1,189
2025
- -
- -
1,120

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.02
2024
- -
- -
-0.01
2025
- -
- -
-0.01

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Business
Bayzed Health Group Inc. operates and oversees a collection of healthcare facilities delivering comprehensive oncology medical services throughout the People's Republic of China. The company provides a full spectrum of cancer care, from initial screening and precise diagnosis to various treatments, rehabilitation, and even hospice support. Furthermore, it offers hospital management expertise and distributes essential pharmaceuticals, medical equipment, and consumables. Founded in 2017 and headquartered in Beijing, China, the group recently listed on the Hong Kong Stock Exchange in June 2025. As of mid-2025, it manages and operates a network of eight hospitals specializing in oncology across multiple Chinese provinces, committed to enhancing the entire patient experience.